These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22163166)

  • 61. Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines.
    Gao L; Wang X; Ma J; Hao D; Wei P; Zhou L; Liu G
    Colloids Surf B Biointerfaces; 2016 Apr; 140():307-316. PubMed ID: 26764117
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhanced digestion inhibition and mucus penetration of F127-modified self-nanoemulsions for improved oral delivery.
    Song W; Yang Y; Yu M; Zhu Q; Damaneh MS; Zhong H; Gan Y
    Asian J Pharm Sci; 2018 Jul; 13(4):326-335. PubMed ID: 32104406
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels.
    Xavier M; García-Hevia L; Amado IR; Pastrana L; Gonçalves C
    Int J Nanomedicine; 2019; 14():9077-9088. PubMed ID: 31819420
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier.
    Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE
    Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
    Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
    Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
    Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
    Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z; Guo H; Zhu X; Jin Y; Huang Y
    J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol.
    Prezotti FG; Boni FI; Ferreira NN; Silva DS; Almeida A; Vasconcelos T; Sarmento B; Gremião MPD; Cury BSF
    Drug Dev Ind Pharm; 2020 Feb; 46(2):236-245. PubMed ID: 31928345
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
    Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
    J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers.
    Gao Y; He Y; Zhang H; Zhang Y; Gao T; Wang JH; Wang S
    J Colloid Interface Sci; 2021 Jan; 582(Pt A):364-375. PubMed ID: 32861041
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
    Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
    Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61.
    Shen H; Liu S; Ding P; Wang L; Ju J; Liang G
    J Pharm Pharmacol; 2018 Apr; 70(4):498-506. PubMed ID: 29433156
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus.
    Laffleur F; Hintzen F; Shahnaz G; Rahmat D; Leithner K; Bernkop-Schnürch A
    Nanomedicine (Lond); 2014 Mar; 9(3):387-96. PubMed ID: 23611618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers.
    Hou J; Wang J; Sun E; Yang L; Yan HM; Jia XB; Zhang ZH
    Drug Deliv; 2016 Nov; 23(9):3248-3256. PubMed ID: 26984338
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Engineering of a Pluronic F127 functionalized magnetite/graphene nanohybrid for chemophototherapy.
    Li Y; Liu J; Dong H; Liu G; Hu H
    Nanotechnology; 2014 Feb; 25(6):065602. PubMed ID: 24434914
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
    Chen L; Sha X; Jiang X; Chen Y; Ren Q; Fang X
    Int J Nanomedicine; 2013; 8():73-84. PubMed ID: 23319859
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
    Han HK; Shin HJ; Ha DH
    Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.